CLOVER CORPORATION ORD
Clover Corporation Posts Strong 1H FY26 Results with Maintained FY26 Guidance
Clover Corporation: 1H FY26 revenue up 17% to $44.1m, gross margin 35.6%; FY26 guidance $92-96m kept, signaling stronger 2H FY26.
Clover Corporation Positions for Continued Growth Following Solid FY25 Performance
High-value nutritional solutions manufacturer Clover Corporation (ASX: CLV) has reported a turnaround in performance for FY2025, underpinned by expansion in Europe and Asia across the nutraceutical, food & beverage, and infant formula sectors. The company recorded a 38% boost in revenue to $48.4 million from $37.6m in the previous corresponding period, while net sales revenue […]
Clover ups revenue on the back of greater infant-formula market stability in China
Baby-formula nutritional oils encapsulater Clover Corporation (ASX: CLV) has increased half-year revenue 60 per cent to $31 million and half-year net profit after tax 209 per cent to $3.2 million after greater regulatory stability was experienced in China, increasing demand. The company, which markets its oils under the NuMega Ingredients brand, increased its financial year […]
